Subcutaneous injection of low molecular weight heparin-induced bleeding Analysis and nursing progress

subcutaneous injection of low molecular weight heparin in patients with bleeding is a common cause of adverse reactions, the paper analyzes relevant factors induced by injection of LMWH subcutaneous hemorrhage, before, during and after injection and proposed improvement measures in line with the relevant factors, aiming at reducing the incidence of subcutaneous hemorrhage caused by injection.